Granular biodurable nanomaterials: No convincing evidence for systemic toxicity

Critical Reviews in Toxicology

Volumn 44, Issue 10, 2014, Pages 849-875

  Moreno Horn, Marcus ^a   Gebel, Thomas ^b  

^a Berlin Office for Occupational Safety Protection of Health and Technical Safety (LAGetSi)   (Germany)

^b FEDERAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (Germany)

Author keywords

Carbon black; Low toxicity dusts; Nanotoxicology; Nuisance dust; Poorly soluble low toxicity particles; Systemic toxicity; Titanium dioxide

Indexed keywords

ALUMINUM OXIDE; CARBON; CARBON BLACK; CERIUM OXIDE; GRANULAR BIODURABLE PARTICLE; MANGANESE DIOXIDE; NANOMATERIAL; NANOPARTICLE; SILICON CARBIDE; SILVER; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; TITANIUM;

BIOACCUMULATION; BIOAVAILABILITY; HEALTH HAZARD; METHODOLOGY; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PRACTICE GUIDELINE; REPRODUCTIVE TOXICITY; REVIEW; SYSTEMATIC REVIEW; TISSUE DISTRIBUTION; TOXICITY TESTING; TRANSPORT KINETICS; ANIMAL; ANIMAL MODEL; CHEMISTRY; DOSE RESPONSE; FACTUAL DATABASE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRADERMAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PROCEDURES;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ANIMALS; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MODELS, ANIMAL; NANOSTRUCTURES; PARTICLE SIZE; TITANIUM; TOXICITY TESTS;

EID: 84910027118     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2014.938802     Document Type: Review

References (84)

1. Aalapati S, Ganapathy S, Manapuram S, Anumolu G, Prakya BM. (2014). Toxicity and bio-accumulation of inhaled cerium oxide nanoparticles in CD1 mice. Nanotoxicology, 8, 786-98.
2. Brook RD, Rajagopalan S, Pope CA III, Brook JR, Bhatnagar A, Diez-Roux AV, et al.; American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. (2010). Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation, 121, 2331-78.
3. Chen J, Dong X, Zhao J, Tang G. (2009). In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection. J Appl Toxicol, 29, 330-7.
4. Cherrie JW, Brosseau LM, Hay A, Donaldson K. (2013). Low-toxicity dusts: current exposure guidelines are not sufficiently protective. Ann Occup Hyg, 57, 685-91.
5. Chithrani BD, Chan WC. (2007). Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett, 7, 1542-50.
6. Cho WS, Kang BC, Lee JK, Jeong J, Che JH, Seok SH. (2013). Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part Fibre Toxicol, 10, 9.
7. Cui Y, Gong X, Duan Y, Li N, Hu R, Liu H, et al. (2010a). Hepatocyte apoptosis and its molecular mechanisms in mice caused by titanium dioxide nanoparticles. J Hazard Mater, 183, 874-80.
8. Cui Y, Liu H, Zhou M, Duan Y, Li N, Gong X, et al. (2010b). Signaling pathway of infl ammatory responses in the mouse liver caused by TiO 2 nanoparticles. J Biomed Mater Res A, 96, 221-9.
9. Cui Y, Liu H, Ze Y, Zhang Z, Hu Y, Cheng Z, et al. (2012). Gene Expression in Liver Injury Caused by Long-term Exposure to Titanium Dioxide Nanoparticles in Mice. Toxicol Sci, 128, 171-85.
10. Cui Y, Chen X, Zhou Z, Lei Y, Ma M, Cao R, et al. (2013). Prenatal exposure to nanoparticulate titanium dioxide enhances depressive-like behaviors in adult rats. Chemosphere, 96, 99-104.
11. Dankovic D, Kuempel E, Wheeler M. (2007). An approach to risk assessment for TiO 2. Inhal Toxicol, 19 Suppl 1, 205-12.
12. Donaldson K, Poland C. (2013). Nanotoxicity: challenging the myth of nano-specific toxicity. Curr Opin Biotechnol, 24, 724-34.
13. Duan Y, Liu J, Ma L, Li N, Liu H, Wang J, et al. (2010). Toxicological characteristics of nanoparticulate anatase titanium dioxide in mice. Biomaterials, 31, 894-9.
14. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, et al. (2006). Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect, 114, 1172-8.
15. EU Commission. (2011/696/EU). Recommendation on the definition of nanomaterial. Available at http://eur-lex.europa.eu/LexUriServ/ LexUriServ.douriOJ:L:2011:275:0038:0040:EN:PDF [Accessed on 20 April 2014].
16. Fabian E, Landsiedel R, Ma-Hock L, Wiench K, Wohlleben W, van Ravenzwaay B. (2008). Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch Toxicol, 82, 151-7.
17. Ferin J, Oberdorster G, Penney DP. (1992). Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol, 6, 535-42.
18. Gao G, Ze Y, Li B, Zhao X, Zhang T, Sheng L, et al. (2012). Ovarian dysfunction and gene-expressed characteristics of female mice caused by long-term exposure to titanium dioxide nanoparticles. J Hazard Mater, 243, 19-27.
19. Gao G, Ze Y, Zhao X, Sang X, Zheng L, Ze X, et al. (2013). Titanium dioxide nanoparticle-induced testicular damage, spermatogenesis suppression, and gene expression alterations in male mice. J Hazard Mater, 258-259, 133-43.
20. Gebel T. (2012). Small difference in carcinogenic potency between GBP nanomaterials and GBP micromaterials. Arch Toxicol, 86, 995-1007.
21. Geraets L, Oomen AG, Schroeter JD, Coleman VA, Cassee FR. (2012). Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: Results from a 28-day exposure study. Toxicol Sci, 127, 463-73.
22. Gosens I, Mathijssen LE, Bokkers BG, Muijser H, Cassee FR. (2014). Comparative hazard identification of nano- and micro-sized cerium oxide particles based on 28-day inhalation studies in rats. Nanotoxicology, 8, 643-53.
23. Graff CL, Pollack GM. (2005). Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci, 94, 1187-95.
24. Gui S, Zhang Z, Zheng L, Cui Y, Liu X, Li N, et al. (2011). Molecular mechanism of kidney injury of mice caused by exposure to titanium dioxide nanoparticles. J Hazard Mater, 195, 365-70.
25. Gui S, Li B, Zhao X, Sheng L, Hong J, Yu X, et al. (2013a). Renal injury and Nrf2 modulation in mouse kidney following chronic exposure to TiO 2 nanoparticles. J Agric Food Chem, 61, 8959-68.
26. Gui S, Sang X, Zheng L, Ze Y, Zhao X, Sheng L, et al. (2013b). Intragastric exposure to titanium dioxide nanoparticles induced nephrotoxicity in mice, assessed by physiological and gene expression modifications. Part Fibre Toxicol, 10, 4.
27. Hu R, Gong X, Duan Y, Li N, Che Y, Cui Y, et al. (2010). Neurotoxicological effects and the impairment of spatial recognition memory in mice caused by exposure to TiO 2 nanoparticles. Biomaterials, 31, 8043-50.
28. Hu R, Zheng L, Zhang T, Cui Y, Gao G, Cheng Z, et al. (2011). Molecular mechanism of hippocampal apoptosis of mice following exposure to titanium dioxide nanoparticles. J Hazard Mater, 191, 32-40.
29. Iavicoli I, Leso V, Bergamaschi A. (2012). Toxicological effects of titanium dioxide nanoparticles: a review of in vivo studies. J Nanomater [Online]. doi:10.1155/2012/964381. Available at: http://www.hindawi. com/journals/jnm/2012/964381/[Accessed on 20 April 2014].
30. ISO. (2008). International Organization for Standardization ISO/ TS27687. Nanotechnologies-terminology and definitions for nanoobjects -nanoparticle, nanofibre and nanoplate. http://www.iso.org/iso/ catalogue-detail?csnumber44278 [Accessed on 20 April 2014].
31. Klimisch HJ, Andreae M, Tillmann U. (1997). A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul Toxicol Pharmacol, 25, 1-5.
32. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, et al. (2002). Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health Part A, 65, 1513-30.
33. LeFevre ME, Green FH, Joel DD, Laqueur W. (1982). Frequency of black pigment in livers and spleens of coal workers: correlation with pulmonary pathology and occupational information. Hum Pathol, 13, 1121-6.
34. Li N, Ma L, Wang J, Zheng L, Liu J, Duan Y, et al. (2010a). Interaction Between Nano-Anatase TiO 2 and Liver DNA from Mice In Vivo. Nanoscale Res Lett, 5, 108-15.
35. Li N, Duan Y, Hong M, Zheng L, Fei M, Zhao X, et al. (2010b). Spleen injury and apoptotic pathway in mice caused by titanium dioxide nanoparticules. Toxicol Lett, 195, 161-8.
36. Liu H, Ma L, Zhao J, Liu J, Yan J, Ruan J, Hong F. (2009). Biochemical toxicity of nano-anatase TiO 2 particles in mice. Biol Trace Elem Res, 129, 170-80.
37. Liu H, Ma L, Liu J, Zhao J, Yan J, Hong F. (2010). T oxicity of nano-anatase TiO2 to mice: Liver injury, oxidative stress. Toxicol Environ Chem, 92, 175-86.
38. Lozano O, Laloy J, Alpan L, Mejia J, Rolin S, Toussaint O, et al. (2012). Effects of SiC nanoparticles orally administered in a rat model: biodistribution, toxicity and elemental composition changes in feces and organs. Toxicol Appl Pharmacol, 264, 232-45.
39. Ma L, Zhao J, Wang J, Liu J, Duan Y, Liu H, et al. (2009). The Acute Liver Injury in Mice Caused by Nano-Anatase TiO 2. Nanoscale Res Lett, 10, 1275-85.
40. Ma L, Liu J, Li N, Wang J, Duan Y, Yan J, et al. (2010). Oxidative stress in the brain of mice caused by translocated nanoparticulate TiO 2 delivered to the abdominal cavity. Biomaterials, 31, 99-105.
41. Nalabotu SK, Kolli MB, Triest WE, Ma JY, Manne NDPK, Katta A, et al. (2011). Intratracheal instillation of cerium oxide nanoparticles induces hepatic toxicity in male Sprague-Dawley rats. Int J Nanomedicine, 6, 2327-35.
42. Nel A, Xia T, Madler L, Li N. (2006). Toxic potential of materials at the nanolevel. Science, 311, 622-7.
43. Niwa Y, Hiura Y, Murayama T, Yokode M, Iwai N. (2007). Nano-sized carbon black exposure exacerbates atherosclerosis in LDL-receptor knockout mice. Circ J, 71, 1157-61.
44. Oberdorster G, Ferin J, Lehnert BE. (1994). Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect, 102, 173-9.
45. Oberd o rster G. (2002). Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal Toxicol, 14, 29-56.
46. Oberdorster G, Oberdorster E, Oberdorster J. (2005). Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect, 113, 823-39.
47. Oberdorster G, Stone V, Donaldson K. (2007). ' Toxicology of nanoparticles: A historical perspective '. Nanotoxicology, 1, 2-25.
48. Onishchenko GE, Erokhina MV, Abramchuk SS, Shaitan KV, Raspopov RV, Smirnova VV, et al. (2012). Effects of titanium dioxide nanoparticles on small intestinal mucosa in rats. Bull Exp Biol Med, 154, 265-70.
49. Park EJ, Park YK, Park K. (2009). Acute toxicity and tissue distribution of cerium oxide nanoparticles by a single oral administration in rats. Toxicol Res (Seoul, Repub Korea), 25, 79-84.
50. Pauluhn J. (2009). Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminium oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol Sci, 109, 152-67.
51. Preining O. (1998). The physical nature of very, very small particles and its impact on their behaviour. J Aerosol Sci, 29, 481-95.
52. Regulation (EC). No 1169 / 2011 of the European Parliament and of the council of 25 October 2011 on the provision of food information to consumers. Available at: http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uriOJ:L:2011:304:0018:0063:EN:PDF [Accessed on 20 April 2014].
53. Regulation (EC). No 1223/2009 of the European Parliament and of the council of 30 November 2009 on cosmetic products. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uriOJ:L:2009 :342:0059:0209:EN:PDF [Accessed on 20 April 2014].
54. Regulation (EU). No 528/2012 of the European Parliament and of the council of 22 May 2012 concerning the making available on the market and use of biocidal products. Available at: http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uriOJ:L:2012:167:0001:0123:EN:PDF [Accessed on 20 April 2014]
55. Roller M, Pott F. (2006). Lung tumor risk estimates from rat studies with not specifically toxic granular dusts. Ann NY Acad Sci, 1076, 266-80.
56. Sang X, Zheng L, Sun Q, Li N, Cui Y, Hu R, et al. (2012). The chronic spleen injury of mice following long-term exposure to titanium dioxide nanoparticles. J Biomed Mater Res Part A, 100, 894-902.
57. Sang X, Li B, Ze Y, Hong J, Ze X, Gui S, et al. (2013). Toxicological mechanisms of nanosized titanium dioxide-induced spleen injury in mice after repeated peroral application. J Agric Food Chem, 61, 5590-9.
58. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdorster G, Kreyling WG. (2004). Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol, 16, 453-9.
59. Sheng L, Wang X, Sang X, Ze Y, Zhao X, Liu D, et al. (2013). Cardiac oxidative damage in mice following exposure to nanoparticulate titaniumdioxide. J Biomed Mater Res A, 101, 3238-46.
60. Shi H, Magaye R, Castranova V, Zhao J. (2013). Titanium dioxide nanoparticles: a review of current toxicological data. Part Fibre Toxicol, 10, 15.
61. Shimizu M, Tainaka H, Oba T, Mizuo K, Umezawa M, Takeda K. (2009). Maternal exposure to nanoparticulate titanium dioxide during the prenatal period alters gene expression related to brain development in the mouse. Part Fibre Toxicol, 6, 20.
62. Sunderman FW Jr. (2001). Nasal toxicity, carcinogenicity, and olfactory uptake of metals. Ann Clin Lab Sci, 31, 3-24.
63. Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, et al. (2009). Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci, 108, 452-61.
64. Takahashi Y, Shinkai Y, Mizuo K, Oshio S, Takeda K. (2010). Prenatal exposure to titanium dioxide nanoparticles increases dopamine levels in the prefrontal cortex and neostriatum of mice. J Toxicol Sci, 35, 749-56.
65. Takeda K, Suzuki K, Ishihara A, Kubo-Irie M, Fujimoto R, Tabata M, et al. (2009). Nanoparticles transferred from pregnant mice to their off spring can damage the genital and cranial nerve systems. J Health Sci, 55, 95-102.
66. Tin-Tin-Win-Shwe, Yamamoto S, Ahmed S, Kakeyama M, Kobayashi T, Fujimaki H. (2006). Brain cytokine and chemokine mRNA expression in mice induced by intranasal instillation with ultrafine carbon black. Toxicol Lett, 163, 153-60.
67. Tj a lve H, Henriksson J. (1999). Uptake of metals in the brain via olfactory pathways. Neurotoxicology, 20, 181-95.
68. Tseng MT, Lu X, Duan X, Hardas SS, Sultana R, Wu P, et al. (2012). Alteration of hepatic structure and oxidative stress induced by intravenous nanoceria. Toxicol Appl Pharmacol, 260, 173-82.
69. van Berlo D, Hullmann M, Schins RP. (2012). Toxicology of ambient particulate matter. EXS, 101, 165-217.
70. van der Zande M, Vandebriel RJ, Van Doren E, Kramer E, Herrera Rivera Z, Serrano-Rojero CS, et al. (2012). Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano, 6, 7427-42.
71. van Ravenzwaay B, Landsiedel R, Fabian E, Burkhardt S, Strauss V, Ma-Hock L. (2009). Comparing fate and effects of three particles of different surface properties: nano-TiO 2, pigmentary TiO 2 and quartz. Toxicol Lett, 186, 152-9.
72. Wang J, Zhou G, Chen C, Yu H, Wang T, Ma Y, et al. (2007). Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett, 168, 176-85.
73. Wang J, Chen C, Liu Y, Jiao F, Li W, Lao F, et al. (2008a). Potential neurological lesion after nasal instillation of TiO 2 nanoparticles in the anatase and rutile crystal phases. Toxicol Lett, 183, 72-80.
74. Wang J, Liu Y, Jiao F, Lao F, Li W, Gu Y, et al. (2008b). Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO 2 nanoparticles. Toxicology, 254, 82-90.
75. Wang J, Li N, Zheng L, Wang S, Wang Y, Zhao X, et al. (2011). P38-Nrf-2 signaling pathway of oxidative stress in micecaused by nanoparticulate TiO 2. Biol Trace Elem Res, 140, 186-97.
76. Wang Y, Chen Z, Ba T, Pu J, Chen T, Song Y, et al. (2013). Susceptibility of Young and Adult Rats to the Oral Toxicity of Titanium Dioxide Nanoparticles. Small, 9, 1742-52.
77. Warheit DB. (2008). How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci, 101, 183-5.
78. Warheit DB. (2013). How to measure hazards/risks following exposures to nanoscale or pigment-grade titanium dioxide particles. Toxicol Lett, 220, 193-204.
79. Wu J, Liu W, Xue C, Zhou S, Lan F, Bi L, et al. (2009). Toxicity and penetration of TiO2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure. Toxicol Lett, 191, 1-8.
80. Xie G, Wang C, Sun J, Zhong G. (2011). Tissue distribution and excretion of intravenously administered titanium dioxide nanoparticles. Toxicol Lett, 205, 55-61.
81. Ze Y, Hu R, Wang X, Sang X, Ze X, Li B, et al. (2014). Neurotoxicity and gene-expressed profile in brain-injured mice caused by exposure to titanium dioxide nanoparticles. J Biomed Mater Res Part A, 102, 470-8.
82. Ze Y, Zheng L, Zhao X, Gui S, Sang X, Su J, et al. (2013). Molecular mechanism of titanium dioxide nanoparticles-induced oxidative injury in the brain of mice. Chemosphere, 92, 1183-9.
83. Zhao J, Li N, Wang S, Zhao X, Wang J, Yan J, et al. (2010). The mechanism of oxidative damage in nephrotoxicity of mice caused by nano-anatase TiO 2. J Exp Nanosci, 5, 447-62.
84. Zhao X, Ze Y, Gao G, Sang X, Li B, Gui S, et al. (2013). Nanosized TiO 2 -induced reproductive system dysfunction and its mechanism in female mice. PLoS One, 8, e59378.